,

NDFS12 – BARDA Presentation: CARB-X: A Novel Non-Dilutive Partnership to Promote Innovation and Foster a Robust Antimicrobials Pipeline

Tyler Merkeley of the Biomedical Advanced Research and Development Authority (BARDA) CARB-X program talks about the novel non-dilutive partnership created to promote innovation and foster a robust antimicrobials pipeline.

 

View Slide Deck

/0 Comments/by
You might also like
SAVE THE DATE: The 12th Annual Non-Dilutive Funding Summit will be on January 11, 2017
NDFS17 NIAID NDFS12 – NCI Presentation: New Initiatives to Accelerate Development of Cancer Therapies in the Era of Precision Medicine
NDFS17 Inflammatix NDFS17 Video: Inflammatix: Our Road to Success with Non-Dilutive Funding
Available Online: Non-Dilutive Funding for Non-US Applicants
BARDA at NDFS
Join hundreds of life science industry leaders at The 18th Annual Non-Dilutive Funding Summit (NDFS) and find out more about non-dilutive funding for your R&D, including funding opportunities through The Biomedical Advanced Research and Development Authority (BARDA). BARDA Returns to NDFS
NDFS17 NIAID Non-Dilutive Funding Mega-Panel: The Relationship Between Industry and Non-Dilutive Sources
NDFS17 NIAID NDFS17 Video: SBIR/STTR Grants & Contracts at NIAID & NIH
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *